ENDP Financial Facts
OTHER INCOME, NET: 902KLess: Net income attributable to noncontrolling interests: 14.17M
See Full Income Statement
Prepaid expenses and other current assets: 39.4M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 6.57B
See Full Balance Sheet
Endo Pharmaceuticals Holdings Inc. (ENDP) Earnings
|
Expand Research on ENDP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +873.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/22 | Q222 | $0.65 | -$0.02 | +$0.67 | $713.83M | $526.35M | N/A |  | | Details | |
| 5/5/22 |  |
Q122 | $0.66 | $0.46 | +$0.20 | $652M | $631.07M |  |
| | Details |
| 2/28/22 | |
Q421 | $0.84 | $0.67 | +$0.17 | $789.43M | $731.4M | = | | | Details |
| 11/4/21 | |
Q321 | $0.80 | $0.46 | +$0.34 | $772M | $665.21M | = | | | Details |
| 8/5/21 | |
Q221 | $0.65 | $0.48 | +$0.17 | $714M | $661.86M | = | | | Details |
| 5/6/21 | |
Q121 | $0.73 | $0.48 | +$0.25 | $718M | $668.65M | = | | | Details |
| 2/25/21 | |
Q420 | $0.75 | $0.48 | +$0.27 | $760.22M | $647.12M | = | | | Details |
| 11/5/20 | |
Q320 | $0.52 | $0.14 | +$0.38 | $635M | $547.8M | = | | | Details |
